AAO 2020: 5-Year Update Confirms Durable Response of Gene Augmentation Therapy for RPE65 Mutation-Associated Inherited Retinal Diseases
Visual function remained improved, and no new safety signals were identified
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.